CVS HEALTH CORPORATION REPORTS STRONG SECOND QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE
CVS Health reported Q2 revenue of $106.1 billion, up 7.3% year-over-year, with Adjusted EPS rising to $2.58 from $1.81 in the prior year. The company significantly raised its full-year 2026 guidance, projecting Adjusted EPS of $7.90-$8.10, up from the prior range of $7.30-$7.50, driven by margin recovery in its Health Care Benefits segment and favorable prior year estimates.
Key figures
- Eps
- 2.58
- Revenue
- 106100000000
- Guidance
- FY26 Adjusted EPS $7.90-$8.10 (raised from $7.30-$7.50); GAAP EPS $6.84-$7.04 (raised from $6.24-$6.44); Cash flow from operations at least $11.5 billion (raised from at least $9.5 billion)
- Revenue Yoy
- 7.3%
- Operating income
- 4703000000
- Adjusted operating income
- 5157000000
- Cash flow from operations ytd
- 10600000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.